CD81 and Parkinson disease: Accordingly, we showed that, when corrected to the generic EV transmembrane protein CD81, L1EV membrane-associated α-synuclein differentiates individuals with iRBD or PD from healthy controls (HCs) with high accuracy (area under the receiver operating characteristic [ROC] curve [AUC] > 0.93).